Glenmark Pharmaceuticals Ltd.

GLENMARK Share PricePharmaceuticals & Drugs

₹2,051.9

0 (0%)

As on September 8, 2025

Exchange Scrips: BSE532296NSEGLENMARKISININE935A01035

Market Cap ₹ 58,012 Cr

P/E Ratio 55.3

Dividend Yield 0.12 %

Performance

Market performance

Open2,062

High2,075.9

Volumes8,42,874

Prev2,051.9

Low2,034.6

As on2025-09-08

Historical performance

1 Year High2,284.8

3 Year High2,284.8

5 Year High2,284.8

1 Year Low1,275.5

3 Year Low363.65

5 Year Low348.5

Fundamentals

Company Valuation

Market Cap (₹Cr)

58,012

Face Value (₹)

P/E Ratio

55.3

Dividend Yield

0.12 %

Investment Returns

1 Year

20.5%

3 Years

435.3%

5 Years

345%

10 Years

104%

Technicals

Indicators	Value	Signal
5-DMA	2,003.58	Bullish
10-DMA	1,971.23	Bullish
20-DMA	1,981.76	Bullish
50-DMA	2,011.6	Bullish
100-DMA	1,751.17	Bullish
200-DMA	1,614.41	Bullish

Shareholding Pattern

Field	Jun-2025	Mar-2025	Dec-2024	Sep-2024	Jun-2024
Promoters	6	6	6	6	6
Foreign Investors	---	---	---	---	---
Domestic Investors	6	6	6	6	6
Public Investors	190204	192718	195053	193943	192624
Government	4	4	3	3	3

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

Negative

Neutral

Positive

The stock has a PE ratio of 55.3.
3Y Stock Price CAGR of the stock is 74.1.
The stock has a beta of 0.7.
In the last financial year, the company had an EBITDA of ₹24651 Million.
The company generated revenue of ₹133217 Million in the previous financial year.

Glenmark Pharmaceuticals Ltd.

2051.90 (0%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1204025.3

No. of Shares: 587 (Approx)

Performance:20.4%

P/L: ₹204025.3

Top Gainers